Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Maxcyte (MXCT) Leases (2020 - 2026)

Maxcyte has reported Leases over the past 6 years, most recently at $10.9 million for Q4 2025.

  • Quarterly Leases rose 1.43% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2025, up 1.43% year-over-year, with the annual reading at $10.9 million for FY2025, 1.43% up from the prior year.
  • Leases was $10.9 million for Q4 2025 at Maxcyte, down from $11.1 million in the prior quarter.
  • Over five years, Leases peaked at $11.5 million in Q1 2025 and troughed at $1.0 million in Q3 2021.
  • The 5-year median for Leases is $10.8 million (2024), against an average of $9.4 million.
  • Year-over-year, Leases soared 2506.18% in 2021 and then decreased 10.5% in 2023.
  • A 5-year view of Leases shows it stood at $5.7 million in 2021, then skyrocketed by 73.18% to $9.9 million in 2022, then grew by 14.09% to $11.2 million in 2023, then decreased by 4.23% to $10.8 million in 2024, then increased by 1.43% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Leases are $10.9 million (Q4 2025), $11.1 million (Q3 2025), and $11.3 million (Q2 2025).